Of note, that study also provided evidence that BOK does not directly induce apoptosis or affect apoptotic responses toward chemotherapeutic drugs, but rather that high BOK levels antagonize transforming growth factor β–induced epithelial-to-mesenchymal transition and may thus slow down malignant transformation (metastasization) of NSCLC. This evidence concerns the gene BOK and non-small cell lung carcinoma.